LPL, encoding lipoprotein lipase, is expressed in CLL patients with aggressive clinical properties, which promotes activating ligands for PPARα (Peroxisome proliferator-activated receptor alpha) and switch energy source to fatty acid [63]. Here, LPL is linked to B-cell chronic lymphocytic leukemia.